47.73.Z - Retail sale of pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0,1 | -11,4 | -7723,7 |
EBITDA | 0,1 | -0 | -1,1 | -2656,3 |
Short time liabilities | 8,5 | 24,3 | 47,5 | 95,4 |
Equity capital | 1,3 | 1,6 | -9,6 | -714,7 |
Operating profit (EBIT) | -0 | -0,2 | -1,3 | -475,5 |
Assets | 10,3 | 26,5 | 38,5 | 45,3 |
Net profit (loss) | 0 | 0,2 | -11,1 | -5213,6 |
Cash | 0,1 | 0,2 | 0,2 | 8,6 |
Net income from sale | 41,8 | 43,9 | 46,9 | 6,9 |
Liabilities and provisions for liabilities | 8,9 | 25 | 48,1 | 92,8 |
Working assets | 9,3 | 7,7 | 8,6 | 11,3 |
Depreciation | 0,2 | 0,2 | 0,2 | 8,1 |
% | % | % | p.p. | |
Profitability of capital | 0,2 | 14 | 116,3 | 102,3 |
Equity capital to total assets | 13,1 | 5,9 | -24,9 | -30,8 |
Gross profit margin | 0 | 0,3 | -24,2 | -24,5 |
EBITDA Margin | 0,3 | -0,1 | -2,3 | -2,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 74 | 202 | 369 | 167 |
Current financial liquidity indicator | 1.093512773513794 | 0.3142450153827667 | 0.17920519411563873 | -0,1 |
Net dept to EBITDA | -1.0755726099014282 | -398.1867370605469 | -35.36600875854492 | 362,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane